Scholarly Index
Jos Jonkers
Oncode Institute; 52,854 total citations; 436 total publications; best world rank #32
Oncode Institute
52,854Total citations
436Total publications
109H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| CRISPR and Genetic Engineering | Lifetime | 118 | NL 6 | 99.47 |
| PARP inhibition in cancer therapy | Lifetime | 32 | NL 1 | 99.40 |
| Cancer Cells and Metastasis | Lifetime | 116 | NL 6 | 99.40 |
| DNA Repair Mechanisms | Lifetime | 169 | NL 6 | 98.98 |
| BRCA gene mutations in cancer | Lifetime | 120 | NL 3 | 98.98 |
| Cancer Research and Treatments | Lifetime | 297 | NL 4 | 98.18 |
| Cancer-related Molecular Pathways | Lifetime | 367 | NL 6 | 98.68 |
| Cancer Mechanisms and Therapy | Lifetime | 568 | NL 4 | 94.65 |
| DNA Repair Mechanisms | 2021-2025 | 57 | NL 3 | 95.80 |
| PARP inhibition in cancer therapy | 2021-2025 | 72 | NL 2 | 97.46 |
| CRISPR and Genetic Engineering | 2021-2025 | 197 | NL 3 | 95.84 |
| Cancer Cells and Metastasis | 2021-2025 | 235 | NL 10 | 92.78 |
| BRCA gene mutations in cancer | 2021-2025 | 250 | NL 6 | 92.71 |
| Estrogen and related hormone effects | 2021-2025 | 863 | NL 26 | 72.16 |